Beta-blockers in Cardiovascular Therapy: A Review

by Camelia C. Diaconu, Dragos R. Marcu, Ovidiu G. Bratu, Ana Maria A. Stanescu, Gina Gheorghe, Andreea A. Hlescu, Dan LD. Mischianu, Maria Manea
Published 2019-10-01

Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers

by Dan Wang, Pratik Neupane, Lotten Ragnarsson, Robert J. Capon, Richard J. Lewis
Published 2018-11-01

Meta-analysis of effect of renin–angiotensin–aldosterone system blockers on contrast-induced nephropathy

by Weidong Wang, Wei Qu, Dan Sun, Xiaodan Liu
Published 2020-05-01

Renoprotection Provided by Dipeptidyl Peptidase-4 Inhibitors in Combination with Angiotensin Receptor Blockers in Patients with Type 2 Diabetic Nephropathy

by Dan-Dan Qiu, Jing Liu, Jing-Song Shi, Yu An, Yong-Chun Ge, Min-Lin Zhou, Song Jiang
Published 2018-01-01

Nimodipine, a calcium channel blocker, delays the spontaneous LH surge in women with regular menstrual cycles: a prospective pilot study

by Nayot Dan, Klachook Shany, Casper Robert F
Published 2013-02-01

Mechanism of action of a β1 blocker in experimental septic shock

by Wei, Chaojie
Published 2016

Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper

by Bernard Cholley, Bruno Levy, Jean-Luc Fellahi, Dan Longrois, Julien Amour, Alexandre Ouattara, Alexandre Mebazaa
Published 2019-11-01

Influence of Blocker Distance Variations in form of Triangle in Front of Cylinder toward Drag Coefficien

by Si Putu Gede Gunawan Tista
Published 2012-11-01

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.

by Mingfei Li, Ying Wang, Ndindam Ndiwane, Michelle B Orner, Natalia Palacios, Brant Mittler, Dan Berlowitz, Lewis E Kazis, Weiming Xia
Published 2021-01-01

circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex

by Fei Xie, Xingyuan Xiao, Dan Tao, Chao Huang, Liang Wang, Feng Liu, Hui Zhang, Haitao Niu, Guosong Jiang
Published 2020-12-01

Distribution d'estrogènes et de bêtabloquants dans les stations d'épuration des eaux résiduaires et dans l'eau de surface

by Gabet-Giraud, Virginie
Published 2009

Practice Variation in Establishing the Adequacy of Beta-Blockers as an Antiarrhythmic Agent in School-Aged Children and Adolescents

by Hilal Al Riyami, MD, Arif Hussain, MD, Andrew Warren, MD, FRCPC, Santokh S. Dhillon, MD, FRCPC
Published 2020-07-01

Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model

by Wende Li, Sen Li, Ivy X. Chen, Yujiao Liu, Rakesh R. Ramjiawan, Chi-Ho Leung, Leo E. Gerweck, Dai Fukumura, Jay S. Loeffler, Rakesh K. Jain, Dan G. Duda, Peigen Huang
Published 2021-03-01

Laporan kasus berbasis bukti: Efektifitas Pemberian Calcium Channel Blocker pada Perdarahan Subaraknoid Akibat Trauma Kepala

by Irawan Mangunatmadja, Anton Dharma Saputra
Published 2020-12-01

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.

by Catherine G Derington, Jordana B Cohen, April F Mohanty, Tom H Greene, James Cook, Jian Ying, Guo Wei, Jennifer S Herrick, Vanessa W Stevens, Barbara E Jones, Libo Wang, Alexander R Zheutlin, Andrew M South, Thomas C Hanff, Steven M Smith, Rhonda M Cooper-DeHoff, Jordan B King, G Caleb Alexander, Dan R Berlowitz, Faraz S Ahmad, M Jason Penrod, Rachel Hess, Molly B Conroy, James C Fang, Michael A Rubin, Srinivasan Beddhu, Alfred K Cheung, Weiming Xian, William S Weintraub, Adam P Bress
Published 2021-01-01

Intensity of hydration changes the role of renin–angiotensin–aldosterone system blockers...

by Xiao-sheng Guo, Deng-xuan Wu, Wei-jie Bei, Hua-long Li, Kun Wang, Ying-ling Zhou, Chong-yang Duan, Shi-qun Chen, Dan Lian, Li-wen Li, Yong Liu, Ning Tan, Ji-yan Chen
Published 2017-05-01

Nouveaux aspects cellulaires et moléculaires du remodelage vasculaire pulmonaire dans l’HTAP

by Ranchoux, Benoît
Published 2015

Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction...

by Anna Meta Dyrvig Kristensen, Ann Bovin, Ann Dorthe Zwisler, Charlotte Cerquira, Christian Torp-Pedersen, Hans Erik Bøtker, Ida Gustafsson, Karsten Tange Veien, Kristian Korsgaard Thomsen, Michael Hecht Olsen, Mogens Lytken Larsen, Olav Wendelboe Nielsen, Per Hildebrandt, Sussie Foghmar, Svend Eggert Jensen, Theis Lange, Thomas Sehested, Tomas Jernberg, Dan Atar, Borja Ibanez, Eva Prescott
Published 2020-05-01

Invisible persons, invisible patients: determining the ethics of hormone-blocker therapy through...

by Bonifacio, Herbert
Published 2010

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors

by Terry Lee, PhD, Alessandro Cau, BSc, Matthew Pellan Cheng, MD, Adeera Levin, MD, Todd C. Lee, MD, Donald C. Vinh, MD, Francois Lamontagne, MD, Joel Singer, PhD, Keith R. Walley, MD, Srinivas Murthy, MD, David Patrick, MD, Oleksa G. Rewa, MD, Brent W. Winston, MD, John Marshall, MD, John Boyd, MD, Karen Tran, MD, Andre C. Kalil, MD, Russell Mcculoh, MD, Robert Fowler, MD, James M. Luther, MD, James A. Russell, MD
Published 2021-07-01